---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-25-000038"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:43:07.182517+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics stockholders elect seven directors and ratify Ernst & Young as auditor for 2025

## Summary
- All seven director nominees elected: Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard S. Nelson, Anne Phillips, Paul Sekhri, Daniel K. Spiegelman.
- Votes for director nominees ranged from 2.07M to 2.18M shares; broker non-votes of 219,013 on each.
- Ratification of Ernst & Young as independent auditor: 2,400,291 For, 3,852 Against, 1,416 Abstain, 0 broker non-votes.

## SEC filing metadata
- accession: 0001641489-25-000038
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148925000038/0001641489-25-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148925000038/vtvt-20250610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-25-000038
- JSON: https://secwatch.observer/filing/0001641489-25-000038.json
- Plain text: https://secwatch.observer/filing/0001641489-25-000038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.